Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

A long-term investor in Apple (AAPL) might be perfectly thrilled at the stock's performance. It has returned 663% over the past 10 years, compared with a return of 261% for the S&P 500 SPX. And ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

People with "young" brains -- brains aging more slowly than their actual age -- are much less likely to die or develop ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.